Real-time · AI · Cross-signal
Multiply Labs, Inc. just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on Multiply Labs, Inc., plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Collaboration Between Multiply Labs and Legend Biotech for Automating Cell Therapy Manufacturing
Sep 24, 2024•over 1 year ago
Contract Type
partnership
Description
Multiply Labs has announced a collaboration with Legend Biotech Corporation to focus on automating cell therapy manufacturing. Legend Biotech will evaluate Multiply Labs' robotic technologies and gain priority access to automated systems. This collaboration aims to enable a more rapid and seamless adoption of robotic technology in the cell therapy space.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months